Human connexin channel specificity of classical and new gap junction inhibitors

Journal of Biomolecular Screening

Volumn 17, Issue 10, 2012, Pages 1339-1347

  Picoli, Christèle ^a   Nouvel, Virginie ^a   Aubry, Fabien ^c   Reboul, Marlène ^c   Duchêne, Adeline ^b   Jeanson, Tiffany ^b   Thomasson, Julien ^b   Mouthon, Franck ^a,b   Charvériat, Mathieu ^b  

^a CEA DSV iMETI SEPIA   (France)

^b THERANEXUS   (France)

^c Fondation Alliance BioSecure   (France)

Author keywords

connexin; dye transfer; gap junction; pharmacological modulation; screening

Indexed keywords

CARBENOXOLONE; CONNEXIN 32; CONNEXIN 40; CONNEXIN 43; GAP JUNCTION PROTEIN; GAP JUNCTION PROTEIN INHIBITOR; GLYCYRRHETINIC ACID; MEFLOQUINE; PROTEIN INHIBITOR; QUINIDINE; THN 02; THN 03; THN 08; THN 09; THN 10; THN 11; THN 12; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN; CELL VIABILITY; DRUG SCREENING; GAP JUNCTION; IC 50; IN VITRO STUDY; INSULINOMA; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CONNEXINS; DRUG EVALUATION, PRECLINICAL; GAP JUNCTIONS; GENE EXPRESSION; HUMANS; RATS; SMALL MOLECULE LIBRARIES;

EID: 84869022475     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057112452594     Document Type: Article

References (30)

1. Simon A.M., Goodenough D.A.. Diverse Functions of Vertebrate Gap Junctions. Trends Cell Biol. 1998 ; 8 (12). 477-483
2. Laird D.W.. Life Cycle of Connexins in Health and Disease. Biochem. J. 2006 ; 394 (Pt. 3). 527-543
3. Nakase T., Naus C.C.. Gap Junctions and Neurological Disorders of the Central Nervous System. Biochim. Biophys. Acta. 2004 ; 1662 (1-2). 149-158
4. Deans M.R., Gibson J.R., Sellitto C., Connors B.W., Paul D.L.. Synchronous Activity of Inhibitory Networks in Neocortex Requires Electrical Synapses Containing Connexin36. Neuron. 2001 ; 31 (3). 477-485
5. Fujimoto E., Sato H., Shirai S., Nagashima Y., Fukumoto K., Hagiwara H., Negishi E., Ueno K., Omori Y., Yamasaki H., et al. Connexin32 as a Tumor Suppressor Gene in a Metastatic Renal Cell Carcinoma Cell Line. Oncogene. 2005 ; 24 (22). 3684-3690
6. Oguro K., Jover T., Tanaka H., Lin Y., Kojima T., Oguro N., Grooms S.Y., Bennett M.V., Zukin R.S.. Global Ischemia-Induced Increases in the Gap Junctional Proteins Connexin 32 (Cx32) and Cx36 in Hippocampus and Enhanced Vulnerability of Cx32 Knock-out Mice. J. Neurosci. 2001 ; 21 (19). 7534-7542
7. van Veen A.A., van Rijen H.V., Opthof T.. Cardiac Gap Junction Channels: Modulation of Expression and Channel Properties. Cardiovasc. Res. 2001 ; 51 (2). 217-229
8. Wang L., Chen J., Sun Y., Zhang F., Zhu J., Hu S., Wang D.H.. Regulation of Connexin Expression after Balloon Injury: Possible Mechanisms for Antiproliferative Effect of Statins. Am. J. Hypertens. 2005 ; 18 (9, Pt. 1). 1146-1153
9. Koulakoff A., Mei X., Orellana J.A., Saez J.C., Giaume C.. Glial Connexin Expression and Function in the Context of Alzheimer's Disease. Biochim Biophys Acta. 2012 ; 1818 (8). 2048-2057
10. Sun J.D., Liu Y., Yuan Y.H., Li J., Chen N.H.. Gap Junction Dysfunction in the Prefrontal Cortex Induces Depressive-Like Behaviors in Rats. Neuropsychopharmacology. 2012 ; 37 (5). 1305-1320
11. Giaume C., Theis M.. Pharmacological and Genetic Approaches to Study Connexin-Mediated Channels in Glial Cells of the Central Nervous System. Brain Res. Rev. 2011 ; 63 (1-2). 160-176
12. Dhein S.. Pharmacology of Gap Junctions in the Cardiovascular System. Cardiovasc. Res. 2004 ; 62 (2). 287-298
13. Davidson J.S., Baumgarten I.M., Harley E.H.. Reversible Inhibition of Intercellular Junctional Communication by Glycyrrhetinic Acid. Biochem. Biophys. Res. Commun. 1986 ; 134 (1). 29-36
14. Harks E.G., de Roos A.D., Peters P.H., de Haan L.H., Brouwer A., Ypey D.L., van Zoelen E.J., Theuvenet A.P.. Fenamates: A Novel Class of Reversible Gap Junction Blockers. J. Pharmacol. Exp. Ther. 2001 ; 298 (3). 1033-1041
15. Elsen F.P., Shields E.J., Roe M.T., Vandam R.J., Kelty J.D.. Carbenoxolone Induced Depression of Rhythmogenesis in the Pre-Botzinger Complex. BMC Neurosci. 2008 ; 9: 46
16. del Corsso C., Srinivas M., Urban-Maldonado M., Moreno A.P., Fort A.G., Fishman G.I., Spray D.C.. Transfection of Mammalian Cells with Connexins and Measurement of Voltage Sensitivity of Their Gap Junctions. Nat. Protoc. 2006 ; 1 (4). 1799-1809
17. Fonseca P.C., Nihei O.K., Savino W., Spray D.C., Alves L.A.. Flow Cytometry Analysis of Gap Junction-Mediated Cell-Cell Communication: Advantages and Pitfalls. Cytometry A. 2006 ; 69 (6). 487-493
18. Abbaci M., Barberi-Heyob M., Blondel W., Guillemin F., Didelon J.. Advantages and Limitations of Commonly Used Methods to Assay the Molecular Permeability of Gap Junctional Intercellular Communication. Biotechniques. 2008 ; 45 (1). 33 56-52 62
19. Ziambaras K., Lecanda F., Steinberg T.H., Civitelli R.. Cyclic Stretch Enhances Gap Junctional Communication between Osteoblastic Cells. J. Bone Miner. Res. 1998 ; 13 (2). 218-228
20. Li Z., Yan Y., Powers E.A., Ying X., Janjua K., Garyantes T., Baron B.. Identification of Gap Junction Blockers Using Automated Fluorescence Microscopy Imaging. J. Biomol. Screen. 2003 ; 8 (5). 489-499
21. Silverman W., Locovei S., Dahl G.. Probenecid, a Gout Remedy, Inhibits Pannexin 1 Channels. Am. J. Physiol. Cell Physiol. 2008 ; 295 (3). C761 - C767
22. Fonseca P.C., Nihei O.K., Urban-Maldonado M., Abreu S., de Carvalho A.C., Spray D.C., Savino W., Alves L.A.. Characterization of Connexin 30.3 and 43 in Thymocytes. Immunol. Lett. 2004 ; 94 (1-2). 65-75
23. Spray D. C., Scemes E., Rozental R., Dermietzel R. An Introduction to Cellular and Molecular Neuroscience;. Byrne J. Roberts J., ed. New York: Academic Press ; 2004: 431-458.
24. Statuto M., Audebet C., Tonoli H., Selmi-Ruby S., Rousset B., Munari-Silem Y.. Restoration of Cell-to-Cell Communication in Thyroid Cell Lines by Transfection with and Stable Expression of the Connexin-32 Gene: Impact on Cell Proliferation and Tissue-Specific Gene Expression. J. Biol. Chem. 1997 ; 272 (39). 24710-24716
25. Wu A., Green C.R., Rupenthal I.D., Moalem-Taylor G.. Role of Gap Junctions in Chronic Pain. J. Neurosci. Res. 2012 ; 90 (2). 337-345
26. Srinivas M. Connexins: A Guide;. Harris A. L. Locke D., ed. New York: Humana-Springer ; 2009: 207-224.
27. Cruikshank S.J., Hopperstad M., Younger M., Connors B.W., Spray D.C., Srinivas M.. Potent Block of Cx36 and Cx50 Gap Junction Channels by Mefloquine. Proc. Natl. Acad. Sci. U. S. A. 2004 ; 101 (33). 12364-12369
28. Srinivas M., Hopperstad M.G., Spray D.C.. Quinine Blocks Specific Gap Junction Channel Subtypes. Proc. Natl. Acad. Sci. U. S. A. 2001 ; 98 (19). 10942-10947
29. Giaume C., Tabernero A., Medina J.M.. Metabolic Trafficking through Astrocytic Gap Junctions. Glia. 1997 ; 21 (1). 114-123
30. Bai D., del Corsso C., Srinivas M., Spray D.C.. Block of Specific Gap Junction Channel Subtypes by 2-Aminoethoxydiphenyl borate (2-APB). J. Pharmacol. Exp. Ther. 2006 ; 319 (3). 1452-1458